| review article | Q7318358 |
| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1016863760 |
| P356 | DOI | 10.2165/00003495-198733030-00002 |
| P698 | PubMed publication ID | 3552596 |
| P2093 | author name string | K L Goa | |
| D M Campoli-Richards | |||
| P2860 | cites work | Efficacy of trimethoprim and sulfamethoxazole in the prevention and treatment of Pneumocystis carinii pneumonitis | Q28363173 |
| Adverse Reactions to Trimethoprim-Sulfamethoxazole in Patients with the Acquired Immunodeficiency Syndrome | Q33476530 | ||
| Adverse reactions to trimethoprim-sulfamethoxazole in hospitalized patients | Q33483246 | ||
| In vitro inhibition of platelet function and coagulation by pentamidine isethionate | Q33499755 | ||
| Pneumocystis carinii pneumonia. Problems in diagnosis and therapy in 24 cases | Q34827723 | ||
| Biological profile and response to anti-pneumocystis agents of Pneumocystis carinii in cell culture | Q35767046 | ||
| Letter: Fatal Herxheimer reaction after pentamidine in Pneumocystis pneumonia | Q39382367 | ||
| Pentamidine isethionate in the treatment of Pneumocystis carinii pneumonia | Q39831996 | ||
| Pneumocystis carinli Pneumonitis | Q40177558 | ||
| Drug therapy in renal failure: dosing guidelines for adults. Part I: Antimicrobial agents, analgesics | Q40286982 | ||
| Interaction between aromatic diamidines and nucleic acids: possible implications for chemotherapy | Q40306902 | ||
| Metabolic and synthetic activities of Pneumocystis carinii in vitro | Q40612514 | ||
| Combination of Pentamidine and Trimethoprim-Sulfamethoxazole in the Therapy of Pneumocystis carinii Pneumonia in Rats | Q40618690 | ||
| Treatment of pneumocystis carinii pneumonia in children | Q40646950 | ||
| Comparison of pentamidine isethionate andtrimethoprim-sulfamethoxazole in the treatment of Pneumocystis carinii pneumonia | Q40666541 | ||
| Clinical characteristics of Pneumocystis carinii pneumonia | Q40714105 | ||
| The treatment of Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome | Q40818480 | ||
| Clinical features of Pneumocystis pneumonia in the acquired immune deficiency syndrome | Q40824230 | ||
| Complications of co-trimoxazole in treatment of AIDS-associated Pneumocystis carinii pneumonia in homosexual men | Q40832328 | ||
| Pentamidine treatment of pneumocystis carinii pneumonitis in an adult with lymphatic leukemia | Q40947996 | ||
| Diabetes mellitus following pentamidine-induced hypoglycemia in humans | Q41598739 | ||
| Diabetogenic effect of pentamidine. In vitro and in vivo studies in a patient with malignant insulinoma | Q41919012 | ||
| In Vitro Effects of Antiprotozoan Drugs and Immune Serum on Pneumocystis carinii | Q41926767 | ||
| PNEUMOCYSTIS CARINII PNEUMONIA AND CONGENITAL HYPOGAMMAGLOBULINAEMIA. | Q42162996 | ||
| Pentamidine-induced hypoglycemia in patients with the acquired immune deficiency syndrome | Q42216342 | ||
| Adverse reactions associated with pentamidine isethionate in AIDS patients: recommendations for monitoring therapy. | Q42216494 | ||
| Pentamidine-associated hypotension and route of administration | Q42626723 | ||
| Pentamidine and renal toxicity | Q42627007 | ||
| Hypoglycemic coma from pentamadine in an AIDS patient | Q42653121 | ||
| Pentamidine and hematuria | Q42653145 | ||
| Pentamidine and pancreatitis | Q43800280 | ||
| An evaluation of the mechanism of action of pentamidine isethionate | Q43928590 | ||
| Pneumocystis carinii pneumonia. Diagnosis by lung biopsy | Q43940017 | ||
| Pulmonary complications of the acquired immunodeficiency syndrome. Report of a National Heart, Lung, and Blood Institute workshop | Q44766680 | ||
| Acquired immune deficiency syndrome (AIDS) trends in the United States, 1978–1982 | Q45861694 | ||
| The action of diamidines and related compounds on nucleoproteins | Q47801366 | ||
| he determination of pentamidine (4,4'-diamidinophenoxypentane) in plasma, urine, and tissues | Q48920657 | ||
| Attempts at prophylaxis for murine Pneumocystis carinii pneumonitis. | Q53770433 | ||
| Pentamidine-induced diabetes mellitus. | Q54483211 | ||
| Pneumocystis carinii pneumonia and altered host resistance: treatment of one patient with pentamidine isethionate. | Q54705695 | ||
| Pentamidine: a review | Q58846629 | ||
| Pharmacologic aspects of pentamidine | Q58848179 | ||
| Pentamidine: Clinical pharmacologic correlations in man and mice | Q58849316 | ||
| Hypoglycaemic effect of pentamidine detected by glucose screen | Q66696112 | ||
| Failure of pentamidine isethionate to provide chemoprophylaxis against Pneumocytis carinii infection in rats | Q66876233 | ||
| Pneumocystis cariniiPneumonia | Q66884479 | ||
| Treatment of Pneumocystis carinii pneumonia in infancy | Q66890368 | ||
| Complement inhibition by amidines and guanidines--in vivo and in vitro results | Q67402313 | ||
| Therapy and prophylaxis of Pneumocystis carinii pneumonia | Q67533133 | ||
| A calcifying topical reaction to mast cell depletors in the rat | Q68554498 | ||
| Pentamidine isothionate levels in lungs, livers, and kidneys of rats after aerosol or intramuscular administration | Q68668536 | ||
| Pneumocystis carinii pneumonia in an adopted Vietnamese infant. A case of diffuse, fulminant disease, with recovery | Q68701902 | ||
| Trimethoprim-sulfamethoxazole or pentamidine for Pneumocystis pneumonia in the acquired immunodeficiency syndrome | Q68804907 | ||
| Trimethoprim-sulfamethoxazole or pentamidine for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. A prospective randomized trial | Q68882155 | ||
| Pneumocystis carinii infection | Q69106866 | ||
| Pneumocystis carinii pneumonia in the United States. Epidemiologic, diagnostic, and clinical features | Q69314172 | ||
| Stability of pentamidine isethionate in 5% dextrose and 0.9% sodium chloride injections | Q69561746 | ||
| Functional and morphological modifications induced in rat islets by pentamidine and other diamidines in vitro | Q69908773 | ||
| CT demonstration of calcified subcutaneous masses following parenteral pentamidine isethionate injection | Q70051115 | ||
| Pneumocystis carinii pneumonia | Q70070924 | ||
| Assessment of therapy for pneumocystis carinii pneumonia. PCP Therapy Project Group | Q70329868 | ||
| Reversal of pentamidine-induced hypoglycaemia with oral diazoxide | Q70340500 | ||
| Treatment of Pneumocystis carinii pneumonitis. A comparative trial of sulfamethoxazole-trimethoprim v pentamidine in pediatric patients with cancer: report from the Children's Cancer Study Group | Q70393104 | ||
| Pentamidine and hypoglycemia | Q70988009 | ||
| Pneumocystis carinii Pneumonitis Occurring in an Adopted Korean Infant | Q71089709 | ||
| Latent Pneumocystis infection of rats, relapse, and chemotherapy | Q71094918 | ||
| Pneumocystis carinii pneumonia: successful diagnosis treatment of two patients with associated malignant processes | Q71110444 | ||
| Unusal complications of pentamidine in the treatment of Pneumocystis carinii pneumonia | Q71140239 | ||
| Prolonged hypoglycemia during pentamidine therapy | Q71140838 | ||
| Pneumocystic carinii pneumonia in children with cancer. Diagnosis and treatment | Q71143388 | ||
| Pentamidine Isethionate in the Treatment of Pneumocystis carinii Pneumonia | Q71143436 | ||
| The effects of antimicrobial agents on ribonucleic acid polymerase | Q71160414 | ||
| Acute pancreatitis associated with pentamidine therapy | Q72083206 | ||
| Cutaneous reaction to trimethoprim-sulfamethoxazole in patients with AIDS and Kaposi's sarcoma | Q72785800 | ||
| Pneumocystis carinii Pneumonia: A Comparison Between Patients with the Acquired Immunodeficiency Syndrome and Patients with Other Immunodeficiencies | Q72811762 | ||
| Interstitial plasma cell pneumonia in infants | Q73150956 | ||
| [A new method of treating interstitial plasma cell pneumonia in premature infant with 5-valent antimony & aromatic diamidines] | Q74829574 | ||
| SUCCESSFUL TREATMENT OF PNEUMOCYSTIS CARINII PNEUMONITIS IN A PATIENT WITH CONGENITAL HYPOGAMMAGLOBULINEMIA | Q78233939 | ||
| Study of the storage and elimination of pentamidine in the mouse and white rat | Q78816902 | ||
| The determination of aromatic amidines in plasma and urine | Q83323518 | ||
| P433 | issue | 3 | |
| P921 | main subject | pneumonia | Q12192 |
| pentamidine | Q416206 | ||
| Pneumocystis carinii | Q2099992 | ||
| pharmacokinetics | Q323936 | ||
| P304 | page(s) | 242-258 | |
| P577 | publication date | 1987-03-01 | |
| P1433 | published in | Drugs | Q3040094 |
| P1476 | title | Pentamidine isethionate. A review of its antiprotozoal activity, pharmacokinetic properties and therapeutic use in Pneumocystis carinii pneumonia | |
| P478 | volume | 33 |
| Q40155580 | Alterations in cysteine proteinase content of rat lung associated with development of Pneumocystis carinii infection |
| Q40620583 | Amidines and guanidines in medicinal chemistry. |
| Q28379412 | Anti-Pneumocystis activities of aromatic diamidoxime prodrugs |
| Q39653055 | Antileishmanial activities of several classes of aromatic dications |
| Q28319910 | Cardiac arrest during treatment of Pneumocystis carinii pneumonia with intravenous pentamidine isethionate |
| Q35981469 | Clinical pharmacokinetics of antibiotics in patients with impaired renal function |
| Q24323333 | Cloning and tissue expression of two putative steroid membrane receptors |
| Q40869021 | Controlled dissolution from wax-coated aerosol particles in canine lungs. |
| Q73064919 | Determination of pentamidine in serum and urine by micellar electrokinetic chromatography |
| Q44315156 | Effect of amidine derivatives on nitric oxide production by Leishmania amazonensis promastigotes and axenic amastigotes |
| Q50781501 | Effect of pentamidine on cytokine (IL-1 beta, TNF alpha, IL-6) production by human alveolar macrophages in vitro. |
| Q37977342 | Effects of drugs on glucose tolerance in non-insulin-dependent diabetics (Part II). |
| Q73134063 | High-performance liquid chromatographic assay detects pentamidine metabolism by Fisher rat liver microsomes |
| Q69385900 | High-performance liquid chromatographic method for the quantification of several diamidine compounds with potential chemotherapeutic value |
| Q37932381 | Inhaled pentamidine. An overview of its pharmacological properties and a review of its therapeutic use in Pneumocystis carinii pneumonia |
| Q72143968 | Insulin-dependent diabetes mellitus following pentamidine therapy in a patient with AIDS |
| Q67968657 | Low incidence of Pneumocystis carinii pneumonia in HIV patients receiving 300 mg pentamidine aerosol every 2 weeks |
| Q45888265 | Management of Pneumocystis carinii pneumonia in patients with AIDS and other conditions: experience in a Philadelphia University Teaching Hospital |
| Q35272089 | Metabolic N-hydroxylation of pentamidine in vitro |
| Q68194967 | Modulation of tumor necrosis factor release from alveolar macrophages treated with pentamidine isethionate |
| Q26825025 | Novel amidines and analogues as promising agents against intracellular parasites: a systematic review |
| Q24649611 | Pentamidine binds to tRNA through non-specific hydrophobic interactions and inhibits aminoacylation and translation |
| Q26751428 | Pentamidine in Pneumocystis jirovecii prophylaxis in heart transplant recipients |
| Q35134470 | Pentamidine uptake and resistance in pathogenic protozoa: past, present and future |
| Q42981868 | Pentamidine uptake in Leishmania donovani and Leishmania amazonensis promastigotes and axenic amastigotes |
| Q69917864 | Pentamidine: which salt? |
| Q71267299 | Pharmacokinetic interaction between intravenous 2',3'-dideoxyinosine and pentamidine in rats |
| Q40913176 | Pharmacokinetic optimisation in the treatment of Pneumocystis carinii pneumonia |
| Q35896802 | Primary and secondary metabolism of pentamidine by rats |
| Q40707163 | Probable pentamidine-induced acute pancreatitis |
| Q69926987 | Rash due to nebulised pentamidine |
| Q46318673 | Relapses following treatment of early-stage Trypanosoma brucei gambiense sleeping sickness with a combination of pentamidine and suramin |
| Q24317424 | Structure and inhibition of human diamine oxidase |
| Q35041254 | Synthesis and antiprotozoal activity of cationic 1,4-diphenyl-1H-1,2,3-triazoles |
| Q41571211 | T-2307 causes collapse of mitochondrial membrane potential in yeast |
| Q40709545 | T-2307, a novel arylamidine, is transported into Candida albicans by a high-affinity spermine and spermidine carrier regulated by Agp2. |
| Q92589948 | The In Vitro Effects of Pentamidine Isethionate on Coagulation and Fibrinolysis |
| Q33772899 | The anti-protozoal drug pentamidine blocks KIR2.x-mediated inward rectifier current by entering the cytoplasmic pore region of the channel. |
| Q38037883 | The effect of respiratory disorders on clinical pharmacokinetic variables |
| Q71615839 | The inhibitory effect of pentamidine on the production of chemotactic cytokines by in vitro stimulated human blood cells |
| Q41566598 | The inhibitory effects of pentamidine on biochemical events in human liver cells |
| Q40859983 | The pharmacology of leishmaniasis |
| Q40721903 | The treatment of human African trypanosomiasis |
| Q37826778 | Therapy and prophylaxis of systemic protozoan infections |
| Q36711483 | Treatment and prophylaxis of Pneumocystis carinii pneumonia in AIDS patients |
Search more.